Cost-effectiveness and ROI of a Case-Finding Program for Familial Hypercholesterolemia in Children in the Netherlands; Early Prostacyclin Therapy and ECLS Use in Patients With Congenital Diaphragmatic Hernia
Listen now
Description
JAMA Pediatrics Editors’ Summary by Dimitri A. Christakis, MD, MPH, Editor in Chief, and Alison A. Galbraith, MD, MPH, Associate Editor, for the June 6, 2023, issue. Related Content: Cost-effectiveness and Return on Investment of a Nationwide Case-Finding Program for Familial Hypercholesterolemia in Children in the Netherlands Association Between Early Prostacyclin Therapy and Extracorporeal Life Support Use in Patients With Congenital Diaphragmatic Hernia
More Episodes
New research finds that iron supplementation for low-risk breastfed infants born at term does not improve psychomotor development. JAMA Pediatrics Editor in Chief Dimitri Christakis, MD, MPH, and JAMA Pediatrics Associate Editor Alison Galbraith, MD, MPH, discuss infant iron supplementation with...
Published 06/12/24
New research finds that an artificial intelligence decision support tool has high accuracy for diagnosing otitis media. Bimal Desai, MD, MBI, Chief Health Informatics Officer at Children’s Hospital of Philadelphia, discusses applications of artificial intelligence in pediatric care with Editor in...
Published 04/01/24